Introduction
Elastic fibres form a network which contributes to the elasticity and resilience of tissues, such as skin, lung and the arterial blood vessels. Mature elastic fibres are composed of two morphologically distinct components, amorphous elastin and 10-12 nm microfibrils. Elastin, the major component of the elastic fibres, is a well-characterized connectivetissue protein which is initially synthesized as a soluble polypeptide of -70 kDa (for recent reviews on elastin, see [ 1-3 1). The fibrillogenesis of elastic fibres is initiated by deposition of microfibrils which provide a scaffold on to which the individual elastin molecules align. This alignment is stabilized by the formation of intermolecular cross-links, known as desmosines, which contribute to the insolubility of elastin. Formation of desmosines is initiated by oxidative de-amination of certain lysyl residues by lysyl oxidase, a copper-dependent enzyme [ 4, 51.
The desmosines (desmosine and isodesmosine) are not found in other mammalian proteins, and consequently, an assay of desmosines provides an index of the quantity of insoluble elastic fibres in tissues
The elastin polypeptides are encoded by an mRNA of -3.5 kb which consists of an -2.2 kb [61.
Abbreviations used: UEI'. unit of evolutionary period; KFI,P, restriction-fragment-length polymorphism; PIC, polymorphism-information content; TNF-a, tumour necrosis factor-a; TGF-/?. transforming growth factor-/?; I'XE, pseudoxanthoma elasticum. coding segment and a relatively large, -1.3 kb, 3'-untranslated region [2] . This mKNA serves as a template for translation of elastin polypeptides in cells, such as aortic-smooth-muscle cells and skin fibroblasts. The newly synthesized polypeptides undergo intracellular post-translational modifications, including the removal of the signal peptide and hydroxylation of certain prolyl residues to form 4-hydroxyproline. The elastin polypeptides are then secreted into the extracellular milieu where they assemble into functional fibres. Insoluble elastic fibres can be degraded by a group of proteolytic enzymes, known as elastases. The classic serine elastases are present in polymorphonuclear leucocytes, while elastase-like metalloproteases are synthesized and secreted by fibroblasts and macrophages, among other cells [7, 81. Thus, elastin fibrillogenesis involves several discrete steps, many of which are enzymically mediated. Consequently, elastin-gene expression and metabolic turnover could be disturbed at any of these steps, potentially leading to deficient elastin fibrillogenesis and manifesting clinically as a connective-tissue disease.
Characterization of the human elastin gene

Gene structure
Cloning of cDNAs corresponding to the human elastin mRNA has allowed elucidation of the entire coding region of human elastin [9, 101 (Fig. 1) . The deduced amino-acid sequence depicts alternating segments of cross-link domains, characterized by 
Alternative splicing
One of the early observations during the cloning of human-elastin cDNAs was that several overlapping clones were identical, with the exception of short sequences that were absent in some clones but present in others [9, 101. Comparison of these sequences in the cDNAs with the corresponding genomic-DNA segments indicated that the differences were caused by alternative splicing of certain exons during post-transcriptional processing of the elastin pre-mRNA. In fact, a total of six exons in the human gene have been reported to be subject to alternative splicing ( Fig. 1 ). Careful analysis of these exons suggests that there are several mechanisms involved in generating the isoforms of elastin. These mechanisms include . This mechanism can provide significant variation within the amino-acid composition of individual elastin polypeptides, and presumably in the function of the elastic fibres in tissues. However, the developmental significance and tissue specificity of alternative splicing has not been elucidated in detail.
Chromosomal location
The recently isolated human-elastin-cDNA clones have also been used in molecular hybridizations to establish the chromosomal location of the humanelastin gene. HinfI and AluI [21] . Recently, a highly informative RFLP, based on a single-base change in exon 20
(A -. G) that converts a serine residue to glycine, has been elucidated [22] . This polymorphism can be detected by PCR amplification of the corresponding genomic segment, followed by digestion of the PCR product with the restriction enzymes 
Regulation of elastin-gene expression
Elucidation of regulatory cis-elements
Analysis of the 5'-flanking region of the humanelastin gene has identified several regulatory elements which potentially control the transcription of the gene [23] . Specifically, sequencing of -2. (CRE) (for review of these elements, see [23] ). The presence of such elements may explain previous observations indicating that elastin-gene expression can be up-regulated by glucocorticoids, and that cyclic AMP can abrogate the cyclic GMP stimulation of elastin production by ligamentum nuchae fibroblasts (see [2] ).
Delineation of functional-promoter activity
Functional analyses of the putative human-elastinpromoter segment have been carried out by constructing a panel of promoter-reporter-gene (chloramphenicol acetyl transferase) constructs [23, 241 . These constructs have then been utilized in transient transfections with a variety of cultured cells, including human-skin fibroblasts. These studies indicated that the basic core promoter necessary for basal expression of the gene was contained within the region -128 to -1, and the upstream sequences contained several up-and down-regulatory elements [23] . The positive-regulatory elements and the core-promoter activity could be explained, at least in part, by the presence of multiple SP-1 -and AP2-binding sites within these regions, which may act as general enhancer elements. Interestingly, in addition to the 5'-upstream sequences, the first introns of both the bovine-and human-elastin genes contain regions of extremely strong sequence similarity [2] . Since it has been recently demonstrated that the first intron of three different collagen genes contain segments that act as enhancer elements of the promoter activity, the strong conservation within intron 1 of the elastin gene suggests the possible presence of an enhancer in this gene. However, functional testing of the homologous segments has thus far not supported this possibility.
Cytokine and hormonal regulation
The presence of multiple cis-elements in the elastinpromoter region has suggested that elastin-gene expression is subject to modulation at the transcriptional level. In fact, recent studies have suggested that tumour necrosis factor-a (TNF-a) decreases elastin-mRNA abundance primarily by suppressing the promoter activity [25] . This suppression was temporarily preceded by rapid and transient up- . At the same time, insulin-like growth factor-1 has been shown to enhance elastin-gene expression. In these studies, increases of elastin production up to 2-4-fold were accompanied by -4-fold increases in the corresponding steady-state levels of mRNA [29] . Although there is preliminary evidence for modulation of elastin-gene expression by selective growth factors and hormone-like substances, the precise mechanistic details are largely unknown.
Molecular pathology of elastin
A variety of heritable and acquired connectivetissue diseases have been shown to affect the elastic fibres, including pseudoxanthoma elasticum (PXE), cutis laxa, and the Huschke-Ollendorff syndrome [30, 311 (Table 1 ). In addition, clinically distinct entities, with phenotypes closely resembling PXE (e.g. elastoderma [32] ) or cutis laxa (e.g. the wrinkly skin syndrome [ 3 l]), can be recognized (Table 1) .
Pseudoxanthoma elasticum (PXE)
The prototypic heritable elastin disease is PXE, which affects elastin-rich tissues including the skin and arterial blood vessels. The elastic fibres are pleomorphic and accumulate in the mid-dermis, where they become calcified. In addition, Hruch's membrane, an elastin-rich sheath behind the retina of the eye, becomes fragmented, resulting in angioid streaks characteristic of PXE. The underlying muta- tion and mechanism of calcification of the elastic fibres in PXE are currently unknown.
Cutis laxa
The cutis laxa syndromes, characterized by loose and sagging skin often associated with pulmonary complications, are characterized by paucity of elastic fibres [ 3 11 . In some cases, elastin-mRNA abundance has been shown to be reduced in fibroblast cultures established from these patients, suggesting deficient synthesis of elastin [32, 331. In one case with cutis laxa and severe early onset pulmonary emphysema, high levels of serum-elastase-likeenzyme activity were detected suggesting an enhanced degradation of the elastic fibres [34] .
The Buschke-Ollendorff syndrome This syndrome is characterized by accumulation of elastin in the skin, in association with radiologically detectable, osteopoikilotic-bone lesions [ 351. Elastin biosynthesis by fibroblast cultures established from the cutaneous lesions of the Huschke-Ollendorff syndrome has been shown to be increased, suggesting that enhanced deposition rather than reduced degradation of the elastic fibres contributes to development of cutaneous elastomas [36] . The precise regulatory mechanisms resulting in altered biosynthesis of elastin in this syndrome have not been elucidated. In fact, it is not yet known whether the primary mutations in these diseases reside within the elastin gene, however, this possibility can now
